An Amazonian brew that contains DMT (Dimethyltryptamine) which leads to extended psychedelic experiences.

For thousands of years, the Amazonian people have consumed ayahuasca as part of religious, healing, and spiritual ceremonies. These ceremonies are often led by shamans who guide the sessions through chants and prayers.

Ayahuasca is being explored for its potential to treat:

A potent hallucinogen that naturally occurs in several plant species with the most common one being the ayahuasca plant.

DMT has been used by South American indigenous communities to gain spiritual insight during shamanic traditional ceremonies. Synthetic DMT was first synthesised by chemist Richard Manske in 1931. DMT was very popular in the 1960s prior to it being banned across most of the world in the 1970s.

DMT is being explored for its potential to treat:

Derived from the tabernatnhe iboga baillon plant, ibogaine is a hallucinogenic stimulant.

For over 2,000 years, the Gabon people have eaten or drank Ibogaine as part of the Bwiti initiation ceremony. Ibogaine was first synthesised in 1966 and psychiatrists in Chile, and the USA began exploring whether Ibogaine could be used to help addiction.

Ibogaine is being explored for its potential to treat:

A classic hallucinogen that is derived from the fungus ergot, commonly found growing on rye.

In the 1930’s Albert Hoffman, a Swiss scientist, accidentally synthesised LSD. He discovered its hallucinatory effects when a drop of LSD touched his skin. In the 1950s, LSD was tested as a treatment for alcohol use disorder. Throughout the 1960s LSD’s popularity increased as a recreational drug.

LSD is being explored for its potential to treat:

A synthetic amphetamine-type stimulant that is often taken in a pill form.

MDMA was first synthesised in 1912. In the 1970s, Alexander Shuglin rediscovered MDMA and began exploring the use of the drug in humans in the context of psychological treatment. The 1980s saw the widespread recreational use of MDMA.

MDMA is being explored for its potential to treat:

Naturally occurring in the psilocybe genus of mushrooms, it may promote neural plasticity. Psilocybin can induce feelings of euphoria, peacefulness, and spiritual awakening.

Psilocybin has been used for thousands of years in religious and spiritual ceremonies for divination, healing, pain relief, and celebrations. In 1958, Albert Hoffman isolated psilocybin from the mushroom P. Mexicana.

Psilocybin is being explored for its potential to treat: